Capitol Vein Blog

Monday, February 20, 2012

New Treatment Option for Varicose Veins


You may have read the recent article on FoxNews.com about a new method to treat varicose veins with a foamed agent. Capitol Vein & Laser participated in the clinical study that assessed whether Varisolve, the medicine referred to in the article, was safe and effective in treating saphenous vein reflux.

Reflux in this vein is the primary cause of lower leg varicose veins. The current optimal treatment uses VNUS Closure, which internally heats the vein, causing it to shrink and obliterate.

One advantage we noted in our Varisolve patients was the absence of any pain during the procedure. Delivering the medication was a bit more cumbersome than performing VNUS Closure, but there was no need for local anesthesia beyond the very first injection site in the leg.

We still believe that the results with VNUS Closure are outstanding, with little discomfort during the procedure, immediate recovery and excellent success. Currently, VNUS Closure is the best method to treat saphenous vein reflux, though as we rethink treatment for varicose veins in future years, Varisolve may play a role.  The data presented to the FDA are still preliminary and additional clinical studies are required. It may be several years before the FDA approves this treatment for use in the United States.

Dr. Garth Rosenberg and Dr. Paul McNeill are recognized leaders in the management of venous disease, teaching on the national level and participating in significant clinical trials concerning new treatments for varicose veins. Either doctor can discuss the Varisolve study or other questions related to your varicose veins, at any of the four offices in Maryland, Virginia or West Virginia.

0 comments :

Post a Comment